Peter Gariscsak

Jun 1, 2023 | cuaj.ca | Peter Gariscsak |Gary Gray |Stephen S. Steele |Dean Elterman

Abstract INTRODUCTION: An estimated 18% of Canadians have overactive bladder (OAB), with approximately 24% of those reporting difficulty adhering to pharmacotherapy. To date, there has been no investigation into barriers facing sacral neuromodulation (SNM) as treatment for OAB in Canada. Current Canadian Urological Association members were invited to participate in an anonymous survey.

May 1, 2023 | cuaj.ca | Charlotte Coleman |Michael J. Leveridge |Peter Gariscsak

License You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.